COVID-19

Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging

Nanox.ARC Image of the Nanox ARC Nanox.ARC Image of the Nanox ARCNanox.ARC presents high powered digital X-ray tubes for 3D…

1 year ago

New GIMOTI Patent Listed in FDA Orange Book

Broad Formulation Patent Expands Protection for GimotiSOLANA BEACH, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty…

1 year ago

Nanox Files 2022 Annual Report on Form 20-F

NEVE ILAN, Israel, May 01, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical…

1 year ago

Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing

MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a…

1 year ago

Akari Therapeutics Reports Full-Year 2022 Financial Results and Highlights

Development of lead asset nomacopan, a novel dual-mechanism inhibitor of complement C5 and leukotriene B4 (LTB4), is focused on two…

1 year ago

Erasca Granted FDA Fast Track Designation for CNS-Penetrant EGFR Inhibitor ERAS-801 in Patients with Glioblastoma

ERAS-801 has demonstrated broad preclinical activity against oncogenic EGFR variants and wildtype alterations Initial THUNDERBBOLT-1 Phase 1 data in patients…

1 year ago

iCAD to Report First Quarter 2023 Financial Results on May 15, 2023

NASHUA, N.H., May 01, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer…

1 year ago

Bioxytran Interview at the Emerging Growth Conference

Wednesday, May 3, 2023 12:35 pm –1:05 pm ESTMedical/Scientific Community Reaction to Peer Reviewed ArticleBOSTON, MASSACHUSETTS, May 01, 2023 (GLOBE…

1 year ago